Fourth Quarter Financial Results
Net income for the quarter reached $364.5 million, or $1.57 per diluted share, up 10% from the $331.7 million, or $1.43 per share, reported in the prior-year period. On an adjusted basis, earnings were $1.72 per diluted share, a 2% increase over the same period in 2023.
Segment performance remained bifurcated between the company’s primary divisions:
- Electronic Instruments Group (EIG): Sales were $1.26 billion, an increase of 6% year-over-year. Segment operating income rose 11% to $347.5 million.
- Electromechanical Group (EMG): Sales were $559.7 million, up 3% from the fourth quarter of 2023. Segment operating income increased 4% to $155.1 million.
Financial Trends
Full-Year Results Context
For the full year 2024, AMETEK reported record net sales of $7.0 billion, a 7% increase over 2023. Annual operating income rose 10% to $1.81 billion. Net income for the full year totaled $1.39 billion, compared to $1.31 billion in the previous fiscal year. Cash flow from operations for the year was reported at $1.6 billion.
Strategic Developments and M&A
AMETEK continued its capital deployment strategy through the acquisition of Virtek Vision International in the fourth quarter. This acquisition adds laser-based projection and inspection systems to the company’s Electronic Instruments Group. For the full year 2024, the company deployed approximately $1.1 billion toward four acquisitions.
Guidance and Outlook
Management issued guidance for the full year 2025, projecting overall sales to increase in the mid-to-high single digits. Earnings per share for 2025 are estimated to be in the range of $6.26 to $6.42, representing an increase of 1% to 4% over 2024 levels. For the first quarter of 2025, AMETEK expects adjusted earnings per share between $1.64 and $1.68.
Performance Summary
AMETEK shares rose 0.53% to close at $228.92 following the release of fourth quarter results. The company reported a 5% increase in quarterly revenue and a 10% increase in net income. Growth was sustained across both EIG and EMG segments, supported by recent acquisitions and margin expansion. Guidance for 2025 indicates a continued trend of single-digit sales growth.